Overview and Scope
Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body's storage and utilization of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone.
Sizing and Forecast
The parathyroid hormone market size has grown steadily in recent years. It will grow from $2.35 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing awareness of parathyroid hormone-related disorders, growing demand for parathyroid hormone analogs, increased government funding for parathyroid hormone research, rising disposable incomes.
The parathyroid hormone market size is expected to see steadily grown in the next few years. It will grow to $3.5 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing geriatric population, expansion of private healthcare sectors, emerging indications, precision medicine, growing awareness of bone health, expanding healthcare access. Major trends in the forecast period include advances in parathyroid hormone testing, advances in drug delivery, combination therapies, digital health integration, sustainability and green initiatives.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Segmentation & Regional Insights
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcaemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Othe End-Users
North America was the largest region in the parathyroid hormone market in 2023. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp
Major Driver Impacting Market Growth
The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones. Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which further leads to an increased risk of fracture. According to the International Osteoporosis Foundation, osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly. The parathyroid hormone, which is naturally produced by the body for regulating calcium levels, is used to reduce the risk of bone fracture in people with osteoporosis and is administered as a daily subcutaneous injection. The increase in osteoporosis is therefore expected to contribute to the growth of the parathyroid hormone market.
Key Industry Players
Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Shire plc, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, Becton Dickinson and Company, Ethicon Inc., Genentech Inc., Medtronic Inc., Mylan Laboratories, Novo Nordisk, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings Inc.
The parathyroid hormone market report table of contents includes:
1. Executive Summary
2. Parathyroid Hormone Market Characteristics
3. Parathyroid Hormone Market Trends And Strategies
4. Parathyroid Hormone Market - Macro Economic Scenario
5. Global Parathyroid Hormone Market Size and Growth
.
.
.
31. Global Parathyroid Hormone Market Competitive Benchmarking
32. Global Parathyroid Hormone Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Parathyroid Hormone Market
34. Parathyroid Hormone Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The Business Research Company published its Parathyroid Hormone Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Parathyroid Hormone market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the Parathyroid Hormone market’s segments- 1) By Disease Type: Hypocalcaemia, Hypoparathyroidism2) By End-User: Hospitals, Clinics, Other.
View Complete Report:https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-changeParathyroid Hormone Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global parathyroid hormone market is expected to decline from $1.78 billion in 2019 to $1.70 billion in 2020 at a compound annual growth rate (CAGR) of -4.4%.
The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges.
Parathyroid glands are four small glands located at the back of your thyroid gland.
These glands produce parathyroid hormone which helps in controlling the calcium and phosphorous levels in the body.The single major disease of parathyroid glands is overactivity of one or more of the parathyroid lobes, which make too much parathyroid hormone, causing a potentially serious calcium imbalance.
Contact us for Parathyroid Tumor Treatment in Delhi, India.
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Parathyroid Hormone Global Market Report 2020-30 by The Business Research Company describes and explains the global parathyroid hormone market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Parathyroid Hormone Global Market Report 2021 covers parathyroid hormone market drivers, parathyroid hormone market trends, parathyroid hormone market segments, parathyroid hormone market growth rate, parathyroid hormone market major players, and parathyroid hormone market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-change The parathyroid hormone market report provides an in-depth analysis of the impact of COVID-19 on the global parathyroid hormone industry, along with revised market numbers due to the effects of the coronavirus and the expected parathyroid hormone market growth numbers 2021-2030.Parathyroid Hormone Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now:hhttps://www.thebusinessresearchcompany.com/sample.aspx?id=3427=smpThe global parathyroid hormone market is expected to grow from $1.72 billion in 2020 to $1.79 billion in 2021 at a compound annual growth rate (CAGR) of 4.1%.
The parathyroid hormone market is expected to reach $2.02 billion in 2025 at a CAGR of 3%.The report covers the parathyroid hormone market segments-1) By Disease Type: Hypocalcemia, Hypoparathyroidism.2) By End-User: Hospitals, Clinics, Other.3) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally.
The global Growth Hormone Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the growth hormone market include Novo Nordisk A/S, Pfizer Inc., Novartis AG, Eli Lily And Company, Merck KGaA, Ipsen S.A., Anhui Anke Biotechnology Co., Ltd, LG Chem Ltd., Ferring B.V., and Genetech Inc.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Growth Hormone Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/growth-hormone-market/download-sampleMarket DynamicsThe global HGH market seems to be quite impressive due to surge in HGH deficiency diseases and increasing application of growth hormones for treating problems like idiopathic short stature, small for gestational age and Turner syndrome.
Other key market drivers are initiatives taken by firms and government bodies for increasing awareness about growth hormone deficiencies and its treatment.
Factors like upsurge in FDA approvals and substantial investment by drug manufacturers for R activities for developing novel drugs are also expected to drive the market significantly.
